LENZ
LENZ Therapeutics
LENZ
LENZ
63 hedge funds and large institutions have $186M invested in LENZ Therapeutics in 2022 Q1 according to their latest regulatory filings, with 11 funds opening new positions, 22 increasing their positions, 14 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
57% less capital invested
Capital invested by funds: $432M → $186M (-$246M)
Holders
63
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$8.87M | |
| 2 | +$4.7M | |
| 3 | +$4.49M | |
| 4 |
BlackRock
New York
|
+$4.31M |
| 5 |
EC
EcoR1 Capital
San Francisco,
California
|
+$3M |
Top Sellers
| 1 | -$8.24M | |
| 2 | -$5.05M | |
| 3 | -$4.69M | |
| 4 |
RSCM
Rock Springs Capital Management
Baltimore,
Maryland
|
-$2.58M |
| 5 |
Morgan Stanley
New York
|
-$1.21M |